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Pregnancy Rate Is Greater When the Corpus Luteum Is Present during the Period of
Progestin Treatment to Synchronize Time of Estrus in Cows and Heifers'
T. SANCHEZ, M.E. WEHRMAN, E.G. BERGFELD, K.E. PETERS, F.N. KOJIMA, A.S. CUPP, V. MARISCAL,
Rj. KITTOK, R.J. RASBY, and J.E. KINDER2
Department of Animal Science, University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0908
ABSTRACT
Our hypothesis was that conception in bovine females would be enhanced if the corpus luteum was present during the period
of progestin treatment to synchronize estrus. In this study, 67 heifers (one replicate) and 124 cows (two replicates) were
randomly assigned to one of two treatment groups. Seven days after estrus (Day 0), all animals were implanted with norgestomet
and the implant remained in place for 10 days. All implants were removed on Day 17. Cows and heifers in one group received
prostaglandin F2, (PGF, 0) on Day 7 of the estrous cycle (PG 7; norgestomet without corpus luteum), and animals in the second
group received PGF, on Day 17 (day of implant removal; PG 17; norgestomet with corpus luteum). All heifers and cows ex-
hibiting behavioral estrus were artificially inseminated 12 h after estrus was detected during a 7-day period following removal
of norgestomet. Blood samples were collected from cows of replicate 1 to determine serum concentrations of progesterone and
17[-estradiol. Percentage of females that had calves as a result of artificial insemination was greater (p < 0.01) in the PG 17
group (87% and 78% cows [two replicates] and 58% heifers) compared to the PG 7 group (31% and 44% cows [two replicates]
and 41% heifers). Concentrations of 17,-estradiol in plasma were not different (p > 0.05; pooled SEM = 0.67) at Day 7 (be-
ginning of the norgestomet treatment; 2.34 and 3.09 pg/ml, respectively); but they were different (p < 0.01) at Days 10 (9.53
and 1.65 pg/ml), 13 (12.22 and 1.31 pg/ml), and 16 (11.76 and 2.82 pg/ml for cows in the PG 7 and PG 17 groups, respectively).
As we hypothesized, incidence of conception in bovine females receiving norgestomet with the corpus luteum present (PG 17)
was greater than in cows treated with norgestomet in the absence of the corpus luteum. Greater concentrations of 17,-estradiol
during the treatment period may contribute to the decreased incidence of conception of cows treated with the synthetic pro-
gestin in the absence of the corpus luteum.
INTRODUCTION
Increased fertility is a goal when many of the strategies
used to control the reproductive system of domestic ani-
mals are incorporated into management systems. Exoge-
nous hormones have been used to synchronize time of be-
havioral estrus among bovine females [1-3], but some of
these treatments lead to decreased fertility. Treatment with
norgestomet, a synthetic progestin, has been used as a part
of the SYNCRO-MATE-B regimen (Sanofi Animal Health,
Overland Park, KS) to synchronize time of estrus in cattle;
however, conception resulting from insemination at the
synchronized estrus is decreased [1, 3]. It has been sug-
gested that lowered pregnancy rates after treatment with
norgestomet may be due to an improper temporal rela-
tionship among estrus, the preovulatory surge of LH, and
ovulation [4]. In another study, delayed selection and/or
maturation of the ovulatory follicle were implicated as fac-
tors involved in reduced fertility when norgestomet was used
to synchronize estrus in cows [5]. In addition, reduced fer-
tility in cows in which time of estrus is synchronized with
norgestomet may result from aberrant uterine function [6].
Effects of norgestomet on luteal life span may be me-
diated through effects on ovarian follicular development,
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which represents a key step in formation of CL with normal
life span in postpartum beef cows [7]. Cows treated with
norgestomet in the absence of a CL have a greater fre-
quency of LH pulses than cows with a CL. This suggests that
norgestomet does not modulate pulsatile secretion of LH
in the same way as the CL [7, 8]. Increased frequency of LH
pulses during norgestomet treatment increases concentra-
tions of 173-estradiol (E2) compared to concentrations in
untreated cows with a CL [7]. Failure of norgestomet to
modulate ovarian follicular development in a manner sim-
ilar to the endogenous progesterone produced by the CL
may be responsible for reduced fertility when norgestomet
is used to synchronize estrus. Therefore, our working hy-
pothesis in the current study was that incidence of concep-
tion would be greater in norgestomet-treated cows in which
a CL was present during the entire treatment period than
in cows in which the CL was regressed at initiation of nor-
gestomet treatment.
MATERIALS AND METHODS
Experimental Protocol
Animals used in this study were 67 heifers (1/4 Angus,
1/4 Hereford, 1/4 Red Poll, 1/4 Pinzgaur), 60 cows of rep-
licate 1 (1/4 Angus, 1/4 Hereford, 1/4 Red Poll, 1/4 Pinz-
gaur), and 64 cows of replicate 2 (1/4 Hereford, 1/4 Angus,
1/4 Gelvieh, 1/4 Simmental). Females were randomly as-
signed to one of two treatments. All animals received the
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synthetic progestin melengestrol acetate (MGA; 0.5 mg per
animal daily) in the feed for 10 days to synchronize day of
estrus (Day 0 = day of estrus). Seven days after estrus, all
animals were treated with implants containing 6 mg of nor-
gestomet (17a-acetoxy-11 -methyl-19-nor-pregn-4-ene-3,20-
dione). The implant was inserted in the top of the ear. Im-
plants remained in place for 10 days to provide a contin-
uous exogenous source of progestin. Cows and heifers as-
signed to be treated with norgestomet in the absence of a
CL (PG 7) received prostaglandin F,, (PGF2,,; The Upjohn
Co., Kalamazoo, MI) to regress the CL on the day of nor-
gestomet insertion (Day 7; n = 34 heifers; n = 29 cows in
replicate 1; n = 32 cows in replicate 2). Animals assigned
to be treated with norgestomet in the presence of a CL (PG
17) received PGF2a on the day of implant removal (Day 17;
n = 33 heifers; n = 31 cows in replicate 1; n = 32 cows
in replicate 2).
After implant removal, cows and heifers were observed
for behavioral estrus three times daily (0600, 1200, and 1800
h). Sterile bulls with a section of their epididymis removed
were fitted with a marking device (chinball) to assist in de-
tection of estrus. Animals were considered to be in estrus
if one or more of three criteria were met, i.e., if at least
one of the following was observed: 1) a female stood for
another female to mount her; 2) a female stood for the bull
to mount her; 3) paint from the bull's chinball appeared
on the female's back in a pattern indicating that she had
been mounted by the bull. Time from norgestomet with-
drawal to detection of behavioral estrus was recorded for
each female. Cows and heifers were artificially inseminated
12 h after detection of estrus. To reduce variation in con-
ception rate due to the quality of semen and differences in
skills of technicians, semen from a single collection was
used and only one technician inseminated cows in each
replicate. After the 7-day period of artificial insemination
(AI), no further breeding occurred for a 7-day period.
Thereafter, cows and heifers were kept in pastures with fer-
tile bulls for 48 days. Palpation of the reproductive tract via
the rectum was performed at 60 days after the last day of
Al. Conceptions to AI were recorded at this time, and date
at which calves were born was used to confirm whether
conception had occurred as a result of Al.
Blood samples were collected by jugular venipuncture
from cows in the PG 7 and PG 17 groups of replicate 1.
Samples were collected every other day from the time of
implant insertion (Day 7) until removal (Day 17), and then
daily through Day 45. These samples were collected in tubes
with EDTA and were placed on ice immediately after col-
lection to minimize degradation of progesterone (P4) be-
fore samples were transported to the laboratory. Within 1
h of collection, plasma was separated by centrifugation at
2500 x g for 15 min and stored at -20°C until assayed for
P4 and E2.
Concentrations of P4 in plasma were quantified by RIA
using a monoclonal antibody (BiosPacific, Emeryville, CA).
This assay has been validated in our laboratory [9]. Intra-
and interassay coefficients of variation were 6.6 and 10.2%,
respectively. Luteal phases of less than 10 days in length,
and situations in which initiation of the rise in progester-
one above 1 ng/ml of plasma did not occur during the first
seven days after detection of behavioral estrus, were con-
sidered to be abnormal patterns of luteal development dur-
ing the estrous cycle subsequent to cessation of treatments.
Concentrations of E2 in plasma were quantified by RIA
using an antiserum to E2 (Lilly Lot #022367 [Indianapolis,
IN] at 1:2 000 000) that has been validated in our laboratory
[8]. The amount of E2 in each sample was calculated with
the Four Parameter Curve Fitting Program [10]. Intra- and
interassay coefficients of variation were 5.5 and 6.3%, re-
spectively.
Statistical Analysis
Average time from implant removal to initiation of be-
havioral estrus was examined by ANOVA with the General
Linear Models procedure (GLM) of the Statistical Analysis
System (SAS) [11]. The effect of treatment on incidence of
conception as a result of artificial insemination was deter-
mined by chi-square analysis with the CATMOD procedure
of SAS [11]. Concentrations of progesterone and 173-estra-
diol in plasma were analyzed by ANOVA using the GLM
procedure for repeated measurements over time [11, 12].
RESULTS
Percentages of animals exhibiting behavioral estrus dur-
ing the 7-day period of AI were not different between treat-
ments. The pooled percentages of animals in estrus during
the 7-day period of Al for the three replicates were 95 (cows,
replicate 1), 91 (cows, replicate 2), and 97% (heifers). The
average time from implant removal to initiation of behav-
ioral estrus was different (p < 0.01) among replicates and
between treatment groups, but there was no treatment-by-
replicate interaction (p > 0.10; Table 1). The mean time
from norgestomet withdrawal to initiation of behavioral es-
trus in females in the PG 7 group (norgestomet without CL)
TABLE 1. Time to behavioral estrus after withdrawal of a norgestomet
implant in cows and heifers.
Group Time to estrusa'b (h)
PG 7C
Replicate 1 cow 62
Replicate 2 cows 48
Heifers 32
PG 1 7d
Replicate 1 cow 70
Replicate 2 cows 52
Heifers 51
aMean hours after removal of norgestomet implant, pooled SEM = 4.3.
bThere was a significant effect of treatment and replicate (p < 0.01).
CNorgestomet without CL.
dNorgestomet with CL.
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TABLE 2. Percentage of females that had calves as a result of artificial insemination, that had calves as a result
of natural service, that were not pregnant after artificial insemination and natural service, or had aborted.
Calved to Calved to
artificial natural Non-
inseminationc service pregnantd Abortionse
Treatment (%) (%) (%) (%)
PG 7a
Replicate 1 cow 28 (8/29) 48 (14/29) 14 (4/29) 10 (3/29)
Relicate 2 cows 44 (14/32) 50 (16/32) 6 (2/32) 0 (0/32)
Heifers 41 (14/34) 38 (13/34) 15 (5/34) 6 (2/34)
PG 17b
Replicate 1 cow 87 (27/31) 6.5 (2/31) 6.5 (2/31) 0 (0/32)
Replicate 2 cows 78 (25/32) 19 (6/32) 3 (1/32) 0 (0/32)
Heifers 58 (19/33) 21 (7/33) 15 (5/33) 6 (2/33)
aNorgestomet without CL.
bNorgestomet with CL.
CThere was a effect of treatment on conception rate to artificial insemination (p > 0.01).
dNot pregnant at palpation.
ePregnant at palpation but did not calve.
was earlier (p < 0.01; 62, 48 [cows], and 32 h [heifers])
than for animals in the PG 17 group (norgestomet with CL),
which showed estrus at 70, 52 (cows), and 51 h (heifers),
respectively (pooled SEM = 4).
Percentages of animals in the three replicates that were
pregnant by AI, pregnant by natural service, or not preg-
nant at the end of the study or that had aborted their con-
ceptus are shown in Table 2. Percentage of females that
were pregnant at 60 days as a result of AI differed between
treatment groups (p < 0.01). In the PG 17 group, 75% of
the females became pregnant to AI, while only 40% in the
PG 7 group became pregnant. No differences in pregnancy
rates were observed (p > 0.10) between replicates and there
was no treatment-by-replicate interaction.
Average date when calves were born differed between
treatment groups (p < 0.01, Table 3). Cows and heifers in
the PG 17 group delivered their calves earlier in the calving
season (76 + 2, mean Julian date) compared to cows and
heifers treated with norgestomet without the CL (84 2).
Concentrations of P4 in plasma during the treatment pe-
riod were greater (p < 0.01) in cows in the PG 17 group
TABLE 3. Average calving date in cows and heifers treated with
norgestomet.
Calving
than in the PG 7 group (Fig. 1). The incidence of short
luteal phases (17%) and delayed CL development (7%) dur-
ing the subsequent estrous cycle was greater in cows from
the PG 7 than in those from the PG 17 group. In the PG
17 group, just 1 of 31 cows (3%) had a shortened luteal
phase, and none of the cows had delayed development of
corpus luteum subsequent to treatment. Representative data
for individual cows are depicted in the profiles for animals
in both treatment groups in Figure 2.
Concentrations of E in plasma were not different at Day
7 (beginning of the norgestomet treatment,p > 0.10); how-
ever, on Days 10, 13, and 16, concentrations of E2 were
greater (p < 0.01) in cows in the PG 7 than in cows in the
PG 17 group (Table 4).
DISCUSSION
In the present study, a greater percentage of females were
pregnant as a result of AI in the PG 17 group (norgestomet
E
o
g dated 
Group (Julian days)
PG 78
Replicate 1 cow 86
Replicate 2 cows 90
Heifers 78
PG 17 b
Replicate 1 cow 74
Replicate 2 cows 80
Heifers 74
aNorgestomet without CL.
bNorgestomet with CL.
CMean + pooled SEM = 2.
dThere was a significant effect of treatment on calving date (p < 0.01).
0)
a-
_p
7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45
Day of treatment period
FIG. 1. Mean concentrations of progesterone (P4) in plasma samples
in PG 7 (norgestomet without corpus luteum) and PG 17 (norgestomet with
corpus luteum) groups. Differences in P4 before Day 17 were due to the
treatment imposed. Differences in P4 after Day 33 were due to differences
in conception rate between the two groups; thus, corpus luteum regression
occurred in a greater percentage of cows from the PG 7 group.
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COW 7179 COW 6004
PG17 P47
COW 9100 COW 5185
c PG17 PG7
4)
a COW 3245 COW 4449
PG17 PG7
7 9 1131517 902 25227295 1 ss7 4304S45 7 9 4s , 15171921 2525272 1 3s527 041 45
Day of the treatment period
FIG. 2. Individual profiles for P4 in cows from PG 7 (norgestomet with-
out corpus luteum) and PG 17 (norgestomet with corpus luteum) groups.
Arrow indicates time of behavioral estrus during period of artificial insem-
ination. Note the abnormal profiles of progesterone in cows (5185 and 4449)
from the PG 7 group subsequent to artificial insemination.
with CL) than in the PG 7 group (norgestomet without CL).
This difference in pregnancy rate between the two treat-
ment groups may have resulted from the greater concen-
trations of E2 over a prolonged period of time in cows in
the PG 7 group as compared to those in the PG 17 group.
We have observed a similar increase in E2 in cows treated
with lower vs. higher doses of exogenous progesterone
[8, 9,13, 14]. Decreased pregnancy rates also occurred in cows
treated with the low dose of P4 [13]. Therefore, pregnancy
appears to be compromised in cows when concentrations
of E are increased for periods of time longer than those
occurring during the normal estrous cycle.
Intrafollicular estrogen is thought to be involved in
modulation of the maturation process of bovine oocytes [15].
Exposure of oocytes to abnormally high concentrations of
estrogen over extended periods of time could lead to ab-
normal development of oocytes in bovine females treated
with norgestomet. Transport of gametes is also under con-
trol of ovarian steroids [16]. Alterations in gamete transport
may result from the prolonged increase in estrogen that
occurs before the time of ovulation and sperm deposition
in the reproductive tract of cows treated with norgestomet.
In bovine females, estrogen and P4 influence endometrial
function [17]. In the present study the synthetic progestin
used to synchronize estrus and the abnormal pattern of es-
trogen in circulation during the treatment period may have
prevented the normal development of the endometrium
required for support of early embryonic development in
some animals. In rats, prolonged increases in estrogen prior
to ovulation result in changes in the intrauterine environ-
ment that are detrimental to early embryonic development
[18, 19].
TABLE 4. Plasma concentrations of E2 (pg/ml) during the period of
treatment with norgestomet.
Day of treatment period
Group 7 10 14 16
PG 7b 2.3 d 9.6d 12.2 d 11.8d
PG 17c 3.1d 1.7e 1.3e 2.8e
aMean pooled SEM = 0.7.
bNorgestomet without CL.
CNorgestomet with CL.
d4eWithin a column, means with different letters differ (p < 0.05).
Altered follicular development may be the reason for
greater concentrations of estrogen in the circulation of nor-
gestomet-treated cows without CL than in cows with a CL.
Administration of low doses of exogenous P4 results in
maintenance of the dominant ovarian follicle for longer pe-
riods of time than in controls and cows administered greater
doses of P4 [14, 20]. It was found that the dominant follicles
of cows treated with the low dose of P4 failed to undergo
atresia as would normally occur and produced more estro-
gen than did the dominant follicles of untreated control
cows in the luteal phase of their estrous cycle [14, 21]. Data
from a recent report indicate that cows treated with nor-
gestomet maintain a dominant follicle for extended periods
of time compared to cows with concentrations of proges-
terone typical of the midluteal phase of the estrous cycle
[22]. Results from the present study are in agreement with
those of a previous study in which norgestomet was ad-
ministered to cows during diestrus and proestrus [6]. When
norgestomet was administered in diestrus (in the presence
of the CL), the normal wave-like pattern of ovarian follic-
ular growth continued to occur. However, when norges-
tomet was administered during proestrus (in the absence
of the CL), the dominant follicle was maintained for the
duration of treatment and there was little development of
medium or small follicles on the ovary. On the basis of
these previous reports [6, 22], we propose that the domi-
nant follicle present on Day 7 of the estrous cycle of cows
in our PG 7 group was the follicle that ovulated when treat-
ment was removed on Day 17. Cows from the PG 17 group
would have ovulated from a dominant follicle that devel-
oped later in the estrous cycle, because the concentration
of P4 present in these cows would have allowed for atresia
of the dominant follicle of the first follicular wave of the
estrous cycle and development of other dominant follicles
would have occurred [20, 22].
In the present study, intervals from cessation of treat-
ment to time of behavioral estrus were not as accurate in
determining the absolute time of initiation of estrus after
treatment cessation as they would have been with more fre-
quent estrous detection. However, comparisons between
the two groups still provide useful information. The earlier
onset of behavioral estrus after norgestomet removal in fe-
males in the PG 7 group as compared to those in the PG
17 group probably occurred as a result of the more ad-
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vanced stage of the ovarian follicles in females in the PG 7
group at the time of treatment removal [22]. Earlier reports
indicate that estrus occurs within 48 h of norgestomet with-
drawal [5]. We have previously reported that the preovu-
latory surge of LH occurs earlier subsequent to norgesto-
met withdrawal than in cows that have had their CL lysed
with PGF2 [8]. These data taken together indicate that the
ovarian follicles of bovine females treated with norgesto-
met produce a hormonal milieu that results in a more rapid
cascade of behavioral (estrus) and physiological (ovulation)
events after norgestomet withdrawal than after lysis of CL
with PGF2 , .
Aberrant follicular development may lead to develop-
ment of abnormal CL because the granulosal and thecal cells
of the follicle are precursors to luteal cells. In the present
study there was a greater incidence of abnormal luteal de-
velopment after norgestomet withdrawal in cows from the
PG 7 than in those from the PG 17 group. This indicates
that the endocrine and/or physiological state before ovu-
lation led to abnormal ovarian function in some animals
during the subsequent estrous cycle. This abnormal ovarian
function could have contributed to the reduced incidence
of conception in cows from the PG 7 as compared to those
from the PG 17 group.
Previous reports indicate that the actions of norgestomet
on follicular development may be mediated by an increase
in frequency of LH pulses [7, 8, 22]. Increased LH pulse fre-
quency may stimulate blood supply to a specific ovarian
follicle, enhancing its development beyond that of other
follicles [7]. The frequency of LH pulses in cows treated
with norgestomet was similar to the pattern of LH pulses
detected in cows given low doses of progesterone [8]. In a
previous study, treatment with norgestomet increased the
number of receptors for LH in granulosal and thecal cells,
thereby increasing the sensitivity of the follicle to elevated
serum concentrations of LH, which resulted in increased
secretion of E2 [23].
When treated with exogenous sources of P4 that result
in 1-2 ng/ml of plasma, heifers have greater concentra-
tions of E2 than do heifers administered a higher dose of
P4 that results in concentrations of 5-7 ng/ml of plasma
[9]. Thus, concentration of P4 in circulation alters ovarian
activity by modulating secretion of estrogen. A higher dose
of progestin than that used in the present study might sup-
press follicular development and estrogen secretion. Fur-
ther research is being conducted in our laboratory to de-
termine whether greater doses of synthetic progestin can
mimic the CL in modulating the endogenous hormonal mi-
lieu.
In summary, when norgestomet was administered in the
presence of the CL (PG 17 treatment), a greater percentage
of heifers and cows were pregnant as a result of insemi-
nation at the synchronized estrus compared to norgesto-
met-treated animals that did not have a CL (PG 7 treat-
ment). Norgestomet-treated animals that did not have a CL
had greater concentrations of E2 in circulation during the
treatment period and had a higher incidence of luteal ab-
normalities during the subsequent estrous cycle than did
norgestomet-treated animals that had a CL during the treat-
ment period. We postulate that this altered endocrine mi-
lieu compromises reproduction by having a detrimental in-
fluence on the oocyte, gamete transport, and/or early
embryonic development. Further research in this area will
elucidate why pregnancy is compromised when synthetic
progestins are administered in the doses currently used in
the cattle industry to synchronize time of estrus in bovine
females. More importantly, research of this nature should
allow for development of procedures to synchronize estrus
that allow for enhanced conception as compared those de-
veloped in the past.
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